These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1832905)

  • 1. Prognostic relevance of cathepsin D versus oestrogen receptors in node negative breast cancers.
    Granata G; Coradini D; Cappelletti V; Di Fronzo G
    Eur J Cancer; 1991; 27(8):970-2. PubMed ID: 1832905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour epidermal growth factor receptor, erbB-2 and cathepsin D in node-negative invasive breast cancer: their impact on the selection of patients for systemic adjuvant therapy.
    Tonkin KS; McKay JW; Stitt LW; Tokmakejian S; Haines DS
    Cancer Prev Control; 1999 Apr; 3(2):131-6. PubMed ID: 10474760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsin D levels in primary breast cancers: relationship with epidermal growth factor receptor, oestrogen receptor and axillary nodal status.
    Sacks NP; Smith K; Norman AP; Greenall M; LeJeune S; Harris AL
    Eur J Cancer; 1993; 29A(3):426-8. PubMed ID: 8398346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer.
    Thorpe SM; Rochefort H; Garcia M; Freiss G; Christensen IJ; Khalaf S; Paolucci F; Pau B; Rasmussen BB; Rose C
    Cancer Res; 1989 Nov; 49(21):6008-14. PubMed ID: 2790815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin B, a prognostic indicator in lymph node-negative breast carcinoma patients: comparison with cathepsin D, cathepsin L, and other clinical indicators.
    Lah TT; Cercek M; Blejec A; Kos J; Gorodetsky E; Somers R; Daskal I
    Clin Cancer Res; 2000 Feb; 6(2):578-84. PubMed ID: 10690542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activator inhibitor-1 and prognosis in primary breast cancer.
    Foekens JA; Schmitt M; van Putten WL; Peters HA; Kramer MD; Jänicke F; Klijn JG
    J Clin Oncol; 1994 Aug; 12(8):1648-58. PubMed ID: 8040677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The prognostic value of cathepsin D concentration in cytosol of primary breast carcinoma].
    Bussen S; Rempen A; Caffier H
    Zentralbl Gynakol; 1995; 117(5):253-9. PubMed ID: 7793167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoradiometric detection of pS2 and total cathepsin D in primary breast cancer biopsies: their correlation with steroid receptors.
    Marsigliante S; Biscozzo L; Correale M; Paradiso A; Leo G; Abbate I; Dragone CD; Storelli C
    Br J Cancer; 1994 Mar; 69(3):550-4. PubMed ID: 8123486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of cathepsin D and c-erbB-2 oncoprotein in a subgroup of node-negative breast cancer patients with low histological grade tumors.
    Gaci Z; Bouin-Pineau MH; Gaci M; Daban A; Ingrand P; Métayé T
    Int J Oncol; 2001 Apr; 18(4):793-800. PubMed ID: 11251176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients.
    Foekens JA; Look MP; Bolt-de Vries J; Meijer-van Gelder ME; van Putten WL; Klijn JG
    Br J Cancer; 1999 Jan; 79(2):300-7. PubMed ID: 9888472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer. An immunohistochemical study.
    Henry JA; McCarthy AL; Angus B; Westley BR; May FE; Nicholson S; Cairns J; Harris AL; Horne CH
    Cancer; 1990 Jan; 65(2):265-71. PubMed ID: 2295049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of cathepsin D assay in breast cancer tissues.
    Itoh Y; Kobayashi S; Iwase H; Yamashita H; Kuzushima T; Iwata H; Yamashita T; Naitoh A; Itoh K; Masaoka A
    J Surg Oncol; 1995 Dec; 60(4):221-6. PubMed ID: 8551729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of cathepsin D concentration in tumor cytosol of primary breast cancer.
    Rodríguez J; Vázquez J; Corte MD; Lamelas M; Bongera M; Corte MG; Alvarez A; Allende M; Gonzalez L; Sánchez M; Vijande M; Garcia Muñiz J; Vizoso F
    Int J Biol Markers; 2005; 20(2):103-11. PubMed ID: 16011040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relative prognostic significance of total cathepsin D and HER-2/neu oncogene amplification in breast cancer. The South Australian Breast Cancer Study Group.
    Seshadri R; Horsfall DJ; Firgaira F; McCaul K; Setlur V; Chalmers AH; Yeo R; Ingram D; Dawkins H; Hahnel R
    Int J Cancer; 1994 Jan; 56(1):61-5. PubMed ID: 8262679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cathepsin D, both a prognostic factor and a predictive factor for the effect of adjuvant tamoxifen in breast cancer. South Sweden Breast Cancer Group.
    Fernö M; Baldetorp B; Borg A; Brouillet JP; Olsson H; Rochefort H; Sellberg G; Sigurdsson H; Killander D
    Eur J Cancer; 1994; 30A(14):2042-8. PubMed ID: 7857700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 associated with cathepsin D in primary breast cancer.
    Marsigliante S; Leo G; Mottaghi A; Biscozzo L; Greco S; Storelli C
    Int J Clin Lab Res; 1993; 23(2):102-8. PubMed ID: 8518412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombospondin-1 and -2 in node-negative breast cancer: correlation with angiogenic factors, p53, cathepsin D, hormone receptors and prognosis.
    Gasparini G; Toi M; Biganzoli E; Dittadi R; Fanelli M; Morabito A; Boracchi P; Gion M
    Oncology; 2001; 60(1):72-80. PubMed ID: 11150912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cathepsin D and prognosis in breast cancer.
    Tandon AK; Clark GM; Chamness GC; Chirgwin JM; McGuire WL
    N Engl J Med; 1990 Feb; 322(5):297-302. PubMed ID: 2296271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytosol cathepsin D in Thai women with breast cancer.
    Chearskul S; Bhothisuwan K; Tunsuphasiri V; Churinthrapun M; Keyanond V; Ornrheabroi S
    J Med Assoc Thai; 1996 Oct; 79(10):654-60. PubMed ID: 8997001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of the prognostic value of cathepsin D levels in breast cancer cytosol.
    Pujol P; Maudelonde T; Daures JP; Rouanet P; Brouillet JP; Pujol H; Rochefort H
    Cancer; 1993 Mar; 71(6):2006-12. PubMed ID: 8443752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.